Bank of America’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Buy
78,957
+14,536
+23% +$692K ﹤0.01% 3578
2025
Q4
$2.41M Sell
64,421
-88,555
-58% -$3.6M ﹤0.01% 3924
2025
Q3
$6.19M Sell
152,976
-35,231
-19% -$1.16M ﹤0.01% 3786
2025
Q2
$4.81M Buy
188,207
+31,052
+20% +$677K ﹤0.01% 3944
2025
Q1
$3.36M Buy
157,155
+136,642
+666% +$3.05M ﹤0.01% 4212
2024
Q4
$431K Sell
20,513
-10,847
-35% -$251K ﹤0.01% 5661
2024
Q3
$706K Sell
31,360
-10,421
-25% -$201K ﹤0.01% 5273
2024
Q2
$701K Buy
41,781
+14,593
+54% +$235K ﹤0.01% 5126
2024
Q1
$352K Sell
27,188
-9,927
-27% -$119K ﹤0.01% 5563
2023
Q4
$430K Buy
37,115
+8,683
+31% +$98K ﹤0.01% 5599
2023
Q3
$363K Buy
28,432
+6,428
+29% +$91.1K ﹤0.01% 5536
2023
Q2
$301K Buy
22,004
+2,163
+11% +$31K ﹤0.01% 5577
2023
Q1
$304K Buy
19,841
+220
+1% +$3.36K ﹤0.01% 5692
2022
Q4
$263K Buy
19,621
+6,098
+45% +$81.8K ﹤0.01% 5767
2022
Q3
$180K Sell
13,523
-100,821
-88% -$1.74M ﹤0.01% 6041
2022
Q2
$2.19M Sell
114,344
-18,235
-14% -$345K ﹤0.01% 4231
2022
Q1
$2.65M Buy
132,579
+2,560
+2% +$51.7K ﹤0.01% 4303
2021
Q4
$2.65M Buy
130,019
+15,680
+14% +$335K ﹤0.01% 4279
2021
Q3
$2.46M Buy
114,339
+1,585
+1% +$38.2K ﹤0.01% 4241
2021
Q2
$3.26M Sell
112,754
-10,838
-9% -$293K ﹤0.01% 3910
2021
Q1
$3.02M Buy
123,592
+21,837
+21% +$493K ﹤0.01% 3885
2020
Q4
$1.98M Sell
101,755
-5,156
-5% -$94.8K ﹤0.01% 3964
2020
Q3
$1.86M Sell
106,911
-22,093
-17% -$471K ﹤0.01% 3738
2020
Q2
$3.39M Sell
129,004
-8,591
-6% -$213K ﹤0.01% 3203
2020
Q1
$3.33M Buy
137,595
+17,058
+14% +$417K ﹤0.01% 3061
2019
Q4
$2.99M Sell
120,537
-5,947
-5% -$138K ﹤0.01% 3691
2019
Q3
$2.7M Sell
126,484
-42,540
-25% -$1.17M ﹤0.01% 3791
2019
Q2
$5.37M Buy
169,024
+57,692
+52% +$1.81M ﹤0.01% 3160
2019
Q1
$3.67M Buy
111,332
+5,817
+6% +$181K ﹤0.01% 3467
2018
Q4
$3.39M Sell
105,515
-12,032
-10% -$454K ﹤0.01% 3378
2018
Q3
$5.04M Buy
117,547
+10,491
+10% +$496K ﹤0.01% 3166
2018
Q2
$4.93M Sell
107,056
-4,481
-4% -$198K ﹤0.01% 3163
2018
Q1
$4.43M Buy
111,537
+24,987
+29% +$925K ﹤0.01% 3189
2017
Q4
$2.9M Sell
86,550
-68,216
-44% -$2.42M ﹤0.01% 3624
2017
Q3
$5.73M Buy
154,766
+41,116
+36% +$1.54M ﹤0.01% 3059
2017
Q2
$4.21M Buy
113,650
+2,756
+2% +$90K ﹤0.01% 3204
2017
Q1
$3.12M Buy
110,894
+19,148
+21% +$540K ﹤0.01% 3481
2016
Q4
$2.69M Buy
91,746
+301
+0.3% +$8.21K ﹤0.01% 3516
2016
Q3
$2.48M Buy
91,445
+22,898
+33% +$518K ﹤0.01% 3471
2016
Q2
$1.28M Sell
68,547
-26,537
-28% -$553K ﹤0.01% 3982
2016
Q1
$2.57M Sell
95,084
-81,115
-46% -$2.33M ﹤0.01% 3355
2015
Q4
$5.31M Buy
176,199
+4,392
+3% +$141K ﹤0.01% 2880
2015
Q3
$5.43M Buy
171,807
+61,011
+55% +$2.23M ﹤0.01% 2801
2015
Q2
$4.31M Buy
110,796
+12,232
+12% +$422K ﹤0.01% 2724
2015
Q1
$3.49M Buy
98,564
+4,691
+5% +$151K ﹤0.01% 2779
2014
Q4
$2.96M Sell
93,873
-4,171
-4% -$115K ﹤0.01% 3010
2014
Q3
$2.2M Buy
98,044
+2,414
+3% +$48.3K ﹤0.01% 3305
2014
Q2
$2.1M Buy
+95,630
New +$1.82M ﹤0.01% 3332

Other funds holding PAHC

Bank of America's PAHC Position: Q1 2026 in Review

Bank of America increased its Phibro Animal Health (PAHC) stake by 23% in Q1 2026, buying an estimated $692K and bringing the position to 78,957 shares worth $4.37M. The position accounts for ﹤0.01% of the portfolio, ranked #3578.

Bank of America first reported a position in PAHC in Q2 2014 and has held it in 48 quarters since. The position peaked at $6.19M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Bank of America held 78,957 shares of Phibro Animal Health worth $4.37M as of Q1 2026.
  • Bank of America bought 14,536 Phibro Animal Health shares in Q1 2026, an estimated $692K.
  • Phibro Animal Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3578 holding.
  • Bank of America first reported a position in Phibro Animal Health in Q2 2014 and has held it in 48 quarters since.
  • Bank of America's Phibro Animal Health position peaked at $6.19M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.